The increasing attention on personalized breast cancer care has resulted in an explosion of
new interactive, tailored, web-based clinical decision tools for guiding treatment decisions in …

Simple Summary Ductal carcinoma in situ (DCIS) is a potential precursor to invasive breast
cancer (IBC). Although in many women DCIS will never become breast cancer, almost all …

Ductal carcinoma in situ (DCIS) is an intraepithelial breast neoplasm accounting for up to
25% of US breast cancers. 1, 2 Treatment for this nonlethal diagnosis remains controversial …

Ductal carcinoma in situ (DCIS) is a highly heterogeneous disease. It presents in a variety of
ways and may or may not progress to invasive cancer, which poses challenges for both …

Purpose Prognostic and treatment uncertainty make ductal carcinoma in situ (DCIS)
complex to manage. The purpose of this study was to describe research that evaluated DCIS …

Background Guidelines recommend shared decision-making (SDM) around mammography
screening for women≥ 75 years old. Objective To use microsimulation modeling to estimate …

Purpose Patients diagnosed with ductal carcinoma in situ (DCIS) face trade-offs when
deciding among different treatments, including surgery, radiation, and endocrine therapy. A …

Purpose To examine whether pre-diagnosis patient-reported health-related quality of life
(HRQOL) and depressive symptoms are associated with local treatment for older women …

PURPOSE Recent studies, including a meta-analysis of 88 trials, have shown higher than
expected rates of recurrence and death in hormone receptor–positive breast cancer. These …

Whilst some of the diversity in management of women with ductal carcinoma in situ (DCIS)
may be explained by tumour characteristics, the role of patient preference and the factors …